货号:A323507 同义名: 磷酸西他列汀一水合物 / MK-0431;MK-0431 phosphate monohydrate
Sitagliptin Phosphate Monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Sitagliptin, the first selective DPP-4 (dipeptidyl peptidase-4) inhibitor approved by the US FDA in 2006 for treatment of type 2 diabetes mellitus, has an IC50 value of 18 nM for DPP-4, which is much more selective than DPP-8 and DPP-9. DPP-4 is a serine peptidase located on the cell surface and is widely distributed in plasma, gastrointestinal tract, kidney, lymph nodes and connective tissue. GLP-1 and GIP can be rapidly inactivated by DPP-4 after secretion in the gastrointestinal tract. By inhibiting DPP-4, sitagliptin increases GLP-1 and GIP levels, while GLP-1 and GIP are glucose-dependent. In activation assays in murine T- and B-cells, sitagliptin did not inhibit T cell proliferation and alter LPS induced proliferation of B cells over a range of 12 nM to 50 nM[3]. In vivo, sitagliptin inhibited plasma DPP4 activity, increased plasma GLP-1 and reduced blood glucose excursion in a dose-dependent manner (plasma efficacious drug concentrations were 200 - 700 nM) with optimal dose of 1 mg/kg (46% inhibition), 3 mg/kg, 3 mg/kg in lean mice, DIO mice and db/db mouse respectively[3]. The oral bioavailability of sitagliptin is 60-90% in rats and dogs[4]. Other research has found that in streptozotocin induced diabetic male wistar rats (intravenous injection of 65 mg/kg 15 min after an intraperitoneal injection of 230 mg/kg nicotinamide), treatment with sitagliptin could significantly decrease the attenuates bone loss and improves mechanical bone strength as well as did not have any effect on glucose levels[5]. |
Dose | Rat: 20 mg/kg[3] (p.o.) |
Administration | p.o. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00541229 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT00961363 | Impaired Glucose Tolerance | Phase 2 | Unknown | - | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Lee-Ming Chuang, MD, PhD 886-2-23123456 ext 65038 leeming@ntu.edu.tw Principal Investigator: Lee-Ming Chuang, MD, PhD Sub-Investigator: Hung-Yuan Li, MD Sub-Investigator: Hung-Ju Lin, MD Sub-Investigator: Chia-Hsiung Chang, MD, PhD Sub-Investigator: Shyang-Rong Shih, MD Sub-Investigator: Tien-Jyun Chang, MD, PhD Sub-Investigator: Jaw-Shiun Tsai, MD 收起 << |
NCT00541229 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.91mL 0.38mL 0.19mL |
9.55mL 1.91mL 0.96mL |
19.11mL 3.82mL 1.91mL |
CAS号 | 654671-77-9 |
分子式 | C16H20F6N5O6P |
分子量 | 523.324 |
别名 | 磷酸西他列汀一水合物 ;MK-0431;MK-0431 phosphate monohydrate |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
H2O: 30 mg/mL(57.33 mM) |
动物实验配方 |
PO 0.5% CMC-Na 30 mg/mL suspension |
Tags: Sitagliptin phosphate | 654671-77-9 | MK-0431 phosphate | DPP4 Inhibitor | Metabolic Enzyme/Protease | Autophagy | Dipeptidyl Peptidase | Autophagy | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Sitagliptin phosphate monohydrate 纯度/质量文件 | Sitagliptin phosphate monohydrate 生物活性 | Sitagliptin phosphate monohydrate 动物研究 | Sitagliptin phosphate monohydrate 临床数据 | Sitagliptin phosphate monohydrate 参考文献 | Sitagliptin phosphate monohydrate 实验方案 | Sitagliptin phosphate monohydrate 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00541229 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT00961363 | Impaired Glucose Tolerance | Phase 2 | Unknown | - | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Lee-Ming Chuang, MD, PhD 886-2-23123456 ext 65038 leeming@ntu.edu.tw Principal Investigator: Lee-Ming Chuang, MD, PhD Sub-Investigator: Hung-Yuan Li, MD Sub-Investigator: Hung-Ju Lin, MD Sub-Investigator: Chia-Hsiung Chang, MD, PhD Sub-Investigator: Shyang-Rong Shih, MD Sub-Investigator: Tien-Jyun Chang, MD, PhD Sub-Investigator: Jaw-Shiun Tsai, MD 收起 << |
NCT00541229 | - | Completed | - | - | |
NCT01590797 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01590797 | - | Completed | - | - | |
NCT00411554 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 3 | Completed | - | - |
NCT00411554 | - | Completed | - | - | |
NCT03115112 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01337440 | Type 2 Diabetes Mellitus ... 展开 >> Chronic Liver Disease 收起 << | Phase 4 | Unknown | March 2013 | Japan ... 展开 >> Internal medicine, Kanazawa university hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD +81-76-265-2233 ttakamura@m-kanazawa.jp Sub-Investigator: Kosuke R Shima, MD 收起 << |
NCT03125694 | Uncontrolled Type 2 Diabetes M... 展开 >>ellitus 收起 << | Phase 3 | Completed | - | Iran, Islamic Republic of ... 展开 >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of 收起 << |
NCT01378117 | Type 2 Diabetes Mellitus ... 展开 >> Hospitalization Hyperglycemia 收起 << | Phase 4 | Completed | - | United States, Georgia ... 展开 >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30324 收起 << |
NCT01485614 | Diabetes Mellitus ... 展开 >> Type 2 Diabetes 收起 << | Phase 3 | Active, not recruiting | October 17, 2019 | - |
NCT01354990 | - | Completed | - | - | |
NCT01703637 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | - | China, Shandong ... 展开 >> YuCheng people's hospital Recruiting Dezhou, Shandong, China, 253000 Contact: Pengfei Li lpf9669@163.com Hospital of SINOTRUK Recruiting Jinan, Shandong, China, 250010 Contact: Xiling Fu fxl1936@163.com Jinan central hospital Recruiting Jinan, Shandong, China, 250010 Contact: Shuguang Pang shuguangpang@163.com The jinan military region general hospital Recruiting Jinan, Shandong, China, 250010 Contact: Zhaoshun Jiang zhaoshunjiang@sohu.com Qianfoshan Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Lin Liao, MD 8615168888260 liaolin@medmail.com.cn People's Hospital of Qingdao Chengyang Recruiting Qingdao, Shandong, China, 266100 Contact: Xiaopang Rao 123raoxiaopang@163.com Zibo central hospital Recruiting Zibo, Shandong, China, 255000 Contact: Xiaodong Zhao 19xiaodong@163.com Zibo eighth people's hospital Recruiting Zibo, Shandong, China, 255000 Contact: Ling Dai +86 13853388549 收起 << |
NCT01354990 | - | Completed | - | - | |
NCT01378117 | - | Completed | - | - | |
NCT00758069 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 2 | Completed | - | - |
NCT01557504 | - | Completed | - | - | |
NCT01374568 | Type 2 Diabetes Mellitus | Phase 4 | Terminated(Study closed by spo... 展开 >>nsor. Funding ended.) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 收起 << |
NCT00758069 | - | Completed | - | - | |
NCT01557504 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT01100125 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Seoul National University Bundang Hospital Seongnam, Korea, Republic of 收起 << |
NCT00541450 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01374568 | - | Terminated(Study closed by spo... 展开 >>nsor. Funding ended.) 收起 << | - | - | |
NCT00541450 | - | Completed | - | - | |
NCT00501657 | Gastroparesis ... 展开 >> Diabetes Mellitus 收起 << | Phase 1 | Completed | - | Australia, South Australia ... 展开 >> Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 收起 << |
NCT01545388 | - | Completed | - | - | |
NCT01545388 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02577003 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02577003 | - | Completed | - | - | |
NCT00420511 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Leadership Sinai Centre for Diabetes Toronto, Ontario, Canada, M5T 3L9 收起 << |
NCT01928199 | Posttransplant Diabetes Mellit... 展开 >>us 收起 << | Phase 2 | Recruiting | December 2019 | United States, Missouri ... 展开 >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rowena Delos Santos, MD 314-362-4547 delossantos@wustl.edu Principal Investigator: Rowena Delos Santos, MD Sub-Investigator: Daniel Brennan, MD Sub-Investigator: Rebecca Cusanelli, RN, MSN Sub-Investigator: Timothy Horwedel, PharmD Sub-Investigator: Jennifer Hagopian, PharmD 收起 << |
NCT00420511 | - | Completed | - | - | |
NCT00820573 | Diabetes | Phase 4 | Completed | - | United States, Texas ... 展开 >> Texas Diabetes Institute San Antonio, Texas, United States, 78207 收起 << |
NCT02650427 | Hepato Carcinoma | Phase 1 | Completed | - | France ... 展开 >> Pitié-Salpêtrière Hospital Paris, France, 75013 收起 << |
NCT00820573 | - | Completed | - | - | |
NCT00960453 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trials Center; Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02576288 | Atherosclerosis ... 展开 >> Inflammation 收起 << | Phase 2 | Recruiting | December 2017 | United States, California ... 展开 >> University of Southern California Health Sciences Campus Recruiting Los Angeles, California, United States, 90033 Contact: Evelyn Gonzalez 323-409-8286 evelyngo@usc.edu Contact: Christina Dieli-Conwright, PhD 323-442-2905 cdieli@usc.edu 收起 << |
NCT02791490 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT03122041 | PCOS | Phase 4 | Completed | - | - |
NCT01092663 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94110 United States, Florida Clinical Pharmacology of Miami Miami, Florida, United States, 33014 United States, Texas Healthcare Discoveries, LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 收起 << |
NCT01703221 | - | Completed | - | - | |
NCT01092663 | - | Completed | - | - | |
NCT00337610 | Type 2 Diabetes Mellitus (T2DM... 展开 >>) 收起 << | Phase 3 | Completed | - | - |
NCT01703221 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01155284 | Type 1 Diabetes | Phase 2 | Completed | - | United States, California ... 展开 >> Rady Children's Hospital San Diego, California, United States, 92123-4282 United States, Minnesota Children's - St. Paul Saint Paul, Minnesota, United States, 55102 United States, South Dakota Sanford Research/USD Sioux Falls, South Dakota, United States, 57104 收起 << |
NCT01155284 | - | Completed | - | - | |
NCT00337610 | - | Completed | - | - | |
NCT01552694 | Inflammation ... 展开 >>Macrophage Infiltration Cardiovascular Disease 收起 << | Phase 3 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02675335 | Diabetic Foot | Phase 3 | Withdrawn | March 2018 | - |
NCT01702298 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01552694 | - | Completed | - | - | |
NCT01702298 | - | Completed | - | - | |
NCT00451113 | Type 2 Diabetes | Phase 2 | Completed | - | Canada, British Columbia ... 展开 >> University of British Columbia Gerontology & Diabetes Research Centre Vancouver, British Columbia, Canada 收起 << |
NCT00477581 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States Research Site Spring Valley, California, United States United States, Florida Research Site Miami, Florida, United States Research Site Pembroke Pines, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States, 46260 Research Site Indianapolis, Indiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Montana Research Site Butte, Montana, United States United States, North Carolina Research Site Winston-Salem, North Carolina, United States United States, Ohio Research Site Cincinatti, Ohio, United States Research Site Marion, Ohio, United States United States, Oregon Research Site Eugene, Oregon, United States Research Site Portland, Oregon, United States United States, South Carolina Research Site Charleston, South Carolina, United States Research Site Greer, South Carolina, United States United States, Texas Research Site Austin, Texas, United States Research Site Corpus Christi, Texas, United States Research Site San Antonio, Texas, United States 收起 << |
NCT01718093 | Type 1 Diabetes | Phase 4 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT01590771 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01590771 | - | Completed | - | - | |
NCT00305604 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00305604 | - | Completed | - | - | |
NCT01488279 | Pre-diabetes ... 展开 >>Impaired Fasting Glucose Impaired Glucose Tolerance 收起 << | Not Applicable | Completed | - | United States, Vermont ... 展开 >> University of Vermont Clinical Research Center South Burlington, Vermont, United States, 05403 收起 << |
NCT02330406 | Dipeptidyl-Peptidase 4 Inhibit... 展开 >>ors LDL Cholesterol Glycosylated Hemoglobin Diabetes Mellitus Coronary Disease 收起 << | Phase 4 | Active, not recruiting | December 2018 | Japan ... 展开 >> Department of Cardiovascular Medicine, Tomishiro Central Hospital Tomishiro, Okinawa, Japan, 901-0243 收起 << |
NCT01257464 | Cystic Fibrosis | Phase 2 | Terminated(Lack of recruitment... 展开 >>) 收起 << | - | Canada, British Columbia ... 展开 >> University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY) Vancouver, British Columbia, Canada, V5Z 1L8 收起 << |
NCT00395343 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01741103 | Diabetes Type I | Not Applicable | Unknown | September 2013 | United States, New York ... 展开 >> 115 Flint Road Recruiting Williamsville, New York, United States, 14221 Contact: Paresh Dandona, MD 716-626-7998 pdandona@kaleidahealth.org 收起 << |
NCT01859793 | Diabetes Athe... 展开 >>rosclerosis 收起 << | Phase 4 | Completed | - | United States, Wisconsin ... 展开 >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT00395343 | - | Completed | - | - | |
NCT01530178 | - | Completed | - | - | |
NCT01530178 | Diabetes Mellitus, Type 1 | Phase 4 | Completed | - | United States, New York ... 展开 >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 收起 << |
NCT02738879 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01859793 | - | Completed | - | - | |
NCT00642798 | Diabetes Mellitus Non-insulin-... 展开 >>dependent 收起 << | Phase 1 | Completed | - | - |
NCT01260246 | Type 2 Diabetes ... 展开 >> Nonalcoholic Steatohepatitis 收起 << | Not Applicable | Terminated(Slow recruitment) | - | Canada, Ontario ... 展开 >> St. Joseph's Health Care London, Ontario, Canada, N6A 4L6 收起 << |
NCT01398592 | Diabetes Mellitus Type 2 | Phase 4 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Bad Oeynhausen, Germany, 32549 Novartis Investigative Site Berlin, Germany, 12347 Novartis Investigative Site Berlin, Germany, 13597 Novartis Investigative Site Berlin, Germany, 14089 Novartis Investigative Site Celle, Germany, 29221 Novartis Investigative Site Hannover, Germany, 30165 Novartis Investigative Site Hannover, Germany, 30167 Novartis Investigative Site Kassel, Germany, 34117 Novartis Investigative Site Kirchhain, Germany, 35274 Novartis Investigative Site Lehrte, Germany, 31275 Novartis Investigative Site Mülheim, Germany, 45468 Novartis Investigative Site Oberhausen, Germany, 46049 Novartis Investigative Site Osnabrück, Germany, 49080 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Stuttgart, Germany, 70378 收起 << |
NCT01488279 | - | Completed | - | - | |
NCT02577016 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02577016 | - | Completed | - | - | |
NCT00832624 | - | Terminated(Business Reasons) | - | - | |
NCT01721382 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... 展开 >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 收起 << |
NCT01227460 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado/Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 收起 << |
NCT02827890 | Diabetes Mellitus Type 2 | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of 收起 << |
NCT00466518 | Kidney Transplant ... 展开 >> Type 2 Diabetes 收起 << | Not Applicable | Completed | - | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-1230 收起 << |
NCT01195090 | Type 2 Diabetes | Phase 4 | Completed | - | Taiwan ... 展开 >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Taipei, Taiwan, 10449 收起 << |
NCT00740363 | Glucose Intolerance | Phase 4 | Completed | - | Norway ... 展开 >> Rikshospitalet Medical Center Oslo, Norway, 0027 收起 << |
NCT00832624 | Diabetes Mellitus Non-insulin-... 展开 >>dependent 收起 << | Phase 4 | Terminated(Business Reasons) | - | - |
NCT02263677 | Type 2 Diabetes ... 展开 >> Non-alcoholic Fatty Liver Disease 收起 << | Phase 4 | Withdrawn(Technical difficulti... 展开 >>es have caused this study to be terminated) 收起 << | - | United States, Missouri ... 展开 >> University of Missouri-Columbia: Diabetes Center Columbia, Missouri, United States, 65212 收起 << |
NCT01195090 | - | Completed | - | - | |
NCT01408888 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 United States, Hawaii For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Honolulu, Hawaii, United States, 96814 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 收起 << |
NCT00509236 | Diabetes Mellitus, Type 2 ... 展开 >> End-Stage Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT01408888 | - | Completed | - | - | |
NCT02655757 | Atherosclerosis ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Phase 4 | Completed | - | China, Beijing ... 展开 >> The General Hospital of PLA Beijing, Beijing, China, 100853 收起 << |
NCT00847080 | Reactive Hypoglycemia | Phase 4 | Completed | - | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico, DF, Mexico, 14000 收起 << |
NCT00509236 | - | Completed | - | - | |
NCT00790205 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00833027 | Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT00686634 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, California ... 展开 >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 收起 << |
NCT00833027 | - | Completed | - | - | |
NCT00686634 | - | Completed | - | - | |
NCT01336322 | Pre-diabetes | Phase 2 | Recruiting | December 2018 | Italy ... 展开 >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD +39 050 995103 stefano.delprato@med.unipi.it Sub-Investigator: Graziano Di Cianni, MD 收起 << |
NCT02318693 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT00790205 | - | Completed | - | - | |
NCT02192853 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Department of Endocrinology, Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT02513771 | HIV-1 Infection | Phase 2 | Completed | - | United States, California ... 展开 >> University of Southern California (1201) Los Angeles, California, United States, 90033-1079 UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, District of Columbia Whitman Walker Health CRS (31791) Washington, District of Columbia, United States, 20009 United States, Missouri Washington University CRS (2101) Saint Louis, Missouri, United States, 63110 United States, New York Cornell CRS (7804) New York, New York, United States, 10011 Columbia Physicians and Surgeons CRS (30329) New York, New York, United States, 10032 University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787) Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27516 Greensboro CRS (3203) Greensboro, North Carolina, United States, 27401 United States, Ohio Univ. of Cincinnati CRS (2401) Cincinnati, Ohio, United States, 45267 Case CRS (2501) Cleveland, Ohio, United States, 44106 The Ohio State Univ. AIDS CRS (2301) Columbus, Ohio, United States, 43210 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS (6201) Philadelphia, Pennsylvania, United States, 19104 Pittsburgh CRS (1001) Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Houston AIDS Research Team CRS (31473) Houston, Texas, United States, 77030 收起 << |
NCT02318693 | - | Completed | - | - | |
NCT02312063 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Japan ... 展开 >> Saiseikai Noe Hospital Osaka Osaka, Japan, 536-0001 Kansai Electric Power Hospital Osaka, Japan, 553-0003 收起 << |
NCT00696826 | Liver Insufficiency | Phase 1 | Completed | - | - |
NCT00969566 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 收起 << |
NCT01112670 | - | Completed | - | - | |
NCT01112670 | Healthy | Phase 4 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver Aurora, Colorado, United States, 80045 收起 << |
NCT00862719 | Leukemia, Myeloid, Acute ... 展开 >> Acute Lymphoblastic Leukemia Myelodysplasia Leukemia, Myelogenous, Chronic Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Completed | - | United States, Indiana ... 展开 >> IU Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT02513771 | - | Completed | - | - | |
NCT03359590 | Pharmacological Action | Phase 2 | Enrolling by invitation | July 30, 2019 | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany 收起 << |
NCT01034111 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00862719 | - | Completed | - | - | |
NCT01970462 | Diabetes Mellitus, Type 2 ... 展开 >> Hyperglycemia 收起 << | Phase 4 | Terminated(Recruitment) | - | United States, Ohio ... 展开 >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43203 收起 << |
NCT01034111 | - | Completed | - | - | |
NCT01970462 | - | Terminated(Recruitment) | - | - | |
NCT01334229 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Canada ... 展开 >> Laval University Quebec, Canada, G1V 0A6 收起 << |
NCT02683525 | Graft vs Host Disease ... 展开 >> Hematopoietic Stem Cell Transplantation 收起 << | Phase 2 | Recruiting | February 28, 2020 | United States, Indiana ... 展开 >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN 317-363-9828 chuntley@iupui.edu Principal Investigator: Sherif Farag, MD, PhD Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN 317-363-9828 chuntley@iupui.edu Principal Investigator: Sherif Farag, MD, PhD 收起 << |
NCT00978796 | Type 1 Diabetes | Phase 4 | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 收起 << |
NCT01720264 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoid Leukemia Hematopoetic Myelodysplasia Leukemia, Myelogenous, Chronic Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Completed | - | United States, Indiana ... 展开 >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, New York New York Medical College/Westchester Medical Center/Maria Fareri Children's Hosptial Valhalla, New York, United States, 10595 收起 << |
NCT01334229 | - | Completed | - | - | |
NCT01095991 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Research Site Neuss, Germany 收起 << |
NCT01686932 | Diabetes Mellitus Type 2 | Phase 4 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Elsterwerda, Germany, 04910 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Magdeburg, Germany, 39112 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Sulzbach-Rosenberg, Germany, 92237 Novartis Investigative Site Wallerfing, Germany, 94574 收起 << |
NCT02015910 | Type II Diabetes | Phase 4 | Terminated(Terminated by the s... 展开 >>ponsor due to slow enrollment) 收起 << | - | United States, District of Col... 展开 >>umbia Medstar Georgetown University Hospital Washington, District of Columbia, United States, 20007 收起 << |
NCT03076112 | Type 2 Diabetes Mellitus | Phase 3 | Recruiting | December 30, 2019 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD 82-31-787-7035 limsoo@snu.ac.kr Contact: Kyoung Min Kim, MD, PHD 82-31-787-7047 kyoungmin02@gmail.com Principal Investigator: Soo Lim, MD, PHD 收起 << |
NCT02536248 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | March 31, 2018 | Canada, Quebec ... 展开 >> Laval University Quebec City, Quebec, Canada, G1V 0A6 收起 << |
NCT02015910 | - | Terminated(Terminated by the s... 展开 >>ponsor due to slow enrollment) 收起 << | - | - | |
NCT00730275 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT00659711 | Type 2 Diabetes | Not Applicable | Unknown | December 2013 | United States, New York ... 展开 >> 115 Flint Road Buffalo, New York, United States, 14221 收起 << |
NCT01512797 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | United States, New York ... 展开 >> New York Obesity Nutrition Research Center, Columbia University New York, New York, United States, 10032 收起 << |
NCT01785043 | DIABETES Mellitus Type 2 Not W... 展开 >>ell Controlled 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Clínic de Barcelona Barcelona, Spain, 08036 收起 << |
NCT01512797 | - | Completed | - | - | |
NCT00944450 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT02294084 | Neoplasms, Adipose Tissue | Phase 4 | Completed | - | Netherlands ... 展开 >> Leiden University Medical Center Leiden, Zuid-Holland, Netherlands, 2333 ZA 收起 << |
NCT00657280 | Heart Failure, Congestive | Early Phase 1 | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00657280 | - | Completed | - | - | |
NCT00730275 | - | Completed | - | - | |
NCT00944450 | - | Completed | - | - | |
NCT02328040 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | United States, New York ... 展开 >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 收起 << |
NCT01038648 | Type 2 Diabetes | Phase 3 | Withdrawn | December 2014 | India ... 展开 >> Dr.Ambady Ramachandran Chennai, Tamil nadu, India, 600 008 收起 << |
NCT01686932 | - | Completed | - | - | |
NCT01159847 | Type 1 Diabetes | Phase 1 Phase 2 | Completed | - | China, Hunan ... 展开 >> Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011 收起 << |
NCT02900417 | Type 2 Diabetes | Not Applicable | Unknown | November 2016 | - |
NCT02406950 | Healthy | Phase 3 | Unknown | August 2015 | Korea, Republic of ... 展开 >> Kyung Hee University Hospital Recruiting Seoul, Korea, Republic of, 130-872 Contact: Weon Kim, MD, PhD 2-958-8170 ext 82 mylovekw@hanmail.net Contact: Jong Shin Woo, MD 2-958-8176 ext 82 snowball77@hanmail.net Sub-Investigator: Jong Shin Woo, MD 收起 << |
NCT01600703 | - | Completed | - | - | |
NCT01600703 | Hyperlipidemia | Phase 2 Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT02328040 | - | Completed | - | - | |
NCT02377388 | Platelet Aggregation During Ac... 展开 >>ute Myocardial Infarction 收起 << | Phase 3 | Recruiting | December 2019 | Brazil ... 展开 >> Heart Institute(InCor)-Acute Coronary Care Unit Recruiting São Paulo, SP, Brazil, 01406000 Contact: Paulo R Genestreti, MD 55 11 2661-5058 paulo.gen@ig.com.br Principal Investigator: Jose C Nicolau, MD,PhD Sub-Investigator: Paulo R Genestreti, MD 收起 << |
NCT00789191 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00789191 | - | Completed | - | - | |
NCT02036515 | - | Completed | - | - | |
NCT03659461 | Type 2 Diabetes Mellitus ... 展开 >> PreDiabetes 收起 << | Not Applicable | Recruiting | January 2020 | Malaysia ... 展开 >> Hospital Sultan Ismail Recruiting Johor Bahru, Johor, Malaysia, 81100 Contact: Chong Shiau Chin, MPHARM +6073565000 shiauchin83@hotmail.com Contact +60361455555 收起 << |
NCT00699322 | Type 2 Diabetes | Phase 4 | Unknown | June 2010 | Korea, Republic of ... 展开 >> Kangnam St. Mary's hospital Recruiting Seoul, Korea, Republic of, 137-701 Sub-Investigator: Seung-Hwan Lee, M.D. Sub-Investigator: Eun-Sook Kim, M.D. Principal Investigator: Kun-Ho Yoon, M.D., Ph.D. 收起 << |
NCT00086515 | Diabetes Mellitus, Type II | Phase 3 | Completed | - | - |
NCT00086515 | - | Completed | - | - | |
NCT02741687 | Hyperglycemia | Phase 4 | Completed | - | United States, Georgia ... 展开 >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30322 收起 << |
NCT00790348 | - | Unknown | - | United States, Michigan ... 展开 >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Berhane Seyoum, MD 313-745-4008 bseyoum@med.wayne.edu Principal Investigator: Berhane Seyoum, MD, MPH 收起 << | |
NCT02741687 | - | Completed | - | - | |
NCT01829464 | Diabetes | Phase 3 | Terminated(Due to potential co... 展开 >>ncerns about liver safety (See Detailed Description)) 收起 << | - | - |
NCT02036515 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00086502 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01829464 | - | Terminated(Due to potential co... 展开 >>ncerns about liver safety (See Detailed Description)) 收起 << | - | - | |
NCT00086502 | - | Completed | - | - | |
NCT00734474 | - | Completed | - | - | |
NCT01006018 | Prediabetic State | Not Applicable | Terminated(Unanticipated delay... 展开 >>s due to sterilization/stabilization testing of GLP-1.) 收起 << | - | United States, Georgia ... 展开 >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 收起 << |
NCT00700817 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02941445 | Polycystic Ovary Syndrome ... 展开 >> Body Weight 收起 << | Phase 4 | Completed | - | - |
NCT00734474 | Diabetes Mellitus, Type 2 | Phase 2 Phase 3 | Completed | - | - |
NCT01169090 | Type 2 Diabetes | Phase 2 | Completed | - | - |
NCT02949193 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Kangbuk Samsung Medical Center Seoul, Korea, Republic of, 110-746 收起 << |
NCT02685345 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Japan ... 展开 >> Yodogawaku, Osaka, Japan, 565-0853 收起 << |
NCT01177813 | - | Completed | - | - | |
NCT01177813 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00087516 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00700817 | - | Completed | - | - | |
NCT02338921 | Type 2 Diabetes | Phase 4 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Soo Lim Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Dong Hwa Lee, MD 收起 << |
NCT01006018 | - | Terminated(Unanticipated delay... 展开 >>s due to sterilization/stabilization testing of GLP-1.) 收起 << | - | - | |
NCT00683735 | Diabetes | Phase 2 Phase 3 | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 收起 << |
NCT01519674 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT00087516 | - | Completed | - | - | |
NCT00364377 | Pre-diabetes | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01519674 | - | Completed | - | - | |
NCT00364377 | - | Completed | - | - | |
NCT01930188 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01137812 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01490918 | Type-II Diabetes Mellitus | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> MedicalExcellence Seoul, Korea, Republic of, 137-701 收起 << |
NCT03061214 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Active, not recruiting | April 17, 2019 | - |
NCT01137812 | - | Completed | - | - | |
NCT02043054 | Type 2 Diabetes Mellitus ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> University Hospitals of Leicester NHS Trust, Diabetes Research Centre Leicester, Leicestershire, United Kingdom, LE5 4PW 收起 << |
NCT01856907 | - | Completed | - | - | |
NCT01820104 | Healthy | Phase 1 | Completed | - | China, Shaanxi ... 展开 >> Department of pharmacy, Xijing Hospital, Fourth Military Medical University Xi'an, Shaanxi, China 收起 << |
NCT02920918 | Heart Failure, Systolic ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 4 | Active, not recruiting | March 2019 | United States, Virginia ... 展开 >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT00939939 | Diabetes Mellitus Type 2 | Phase 4 | Terminated(Recruitment failure... 展开 >>) 收起 << | - | Germany ... 展开 >> Medical Dept. 2, Grosshadern, University Munich Munich, Germany, 81377 收起 << |
NCT01119846 | - | Completed | - | - | |
NCT01119846 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 收起 << |
NCT00094757 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01316835 | - | Unknown | December 2011 | Taiwan ... 展开 >> Kaohsiung Chang Gung Memorial Hospita Recruiting Kaohsiung, Taiwan Contact: Ching-Jung Hsieh, MD 886-7-7317123 rose@adm.cgmh.org.tw 收起 << | |
NCT02301806 | Type 2 Diabetes | Phase 4 | Unknown | July 2017 | Japan ... 展开 >> Dokkyo Medical University Recruiting Mibu, Tochigo, Japan, 321-0293 Contact: Yoshimasa Aso, MD 81-282-86-1111 yaso@dokkyomed.ac.jp Principal Investigator: Yoshimasa Aso, MD Recruiting Mibu, Japan 收起 << |
NCT00371007 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00650143 | Acute Myocardial Infarction | Phase 2 Phase 3 | Unknown | December 2013 | Germany ... 展开 >> Clinic of the University of Munich-Grosshadern, Department of Cardiology Recruiting Munich, Germany, 81377 Sub-Investigator: Hans D Theiss, Dr. 收起 << |
NCT00754988 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT01709305 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT02956044 | Type2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Clinical Research Site Evansville, Indiana, United States, 47710 收起 << |
NCT00094757 | - | Completed | - | - | |
NCT01856907 | Disorder of Glucose Regulation | Phase 4 | Completed | - | United States, Louisiana ... 展开 >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 收起 << |
NCT00696982 | Diabetes Mellitus ... 展开 >> Arterial Stiffness 收起 << | Not Applicable | Unknown | June 2009 | Israel ... 展开 >> Department of Internal Medicine A , Research & Development unit Assaf Harofeh Medical Center, Zerifin, affiliated to Sackler School of Medicine, Tel Aviv, Israel Recruiting Zrifin, Israel, 70300 Contact: Shlomit Koren, MD 972-546-888=385 shlomitks@gmail.com Contact: Shai Efrati, MD 972-577-346-364 efratishai@013.net Principal Investigator: Shlomit Koren, MD 收起 << |
NCT02122380 | Polycystic Ovary Syndrome | Phase 4 | Active, not recruiting | July 1, 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02284893 | - | Completed | - | - | |
NCT01709305 | - | Completed | - | - | |
NCT02284893 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02623998 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | December 2018 | Canada, Alberta ... 展开 >> University of Calgary Calgary, Alberta, Canada, T2T 5C7 Canada, Manitoba Health Science Centre Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario McMaster University Hamilton, Ontario, Canada St. Joseph's Hospital London, Ontario, Canada, N6A 4V2 LMC Markham, Ontario, Canada Canada, Quebec Univeristy of Montreal Montreal, Quebec, Canada 收起 << |
NCT01582308 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT02099110 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02607865 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01046110 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01582308 | - | Completed | - | - | |
NCT01065766 | - | Completed | - | - | |
NCT02683187 | Healthy | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Leslie Willis Durham, North Carolina, United States, 27707 收起 << |
NCT02099110 | - | Completed | - | - | |
NCT01046110 | - | Completed | - | - | |
NCT01065766 | - | Completed | - | - | |
NCT00481663 | Type II Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT01751321 | Type 2 Diabetes | Not Applicable | Unknown | October 2013 | - |
NCT00770081 | Diabetes Mellitus, Type 2 ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Completed | - | - |
NCT00425490 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | Israel ... 展开 >> Sheba_Medical_Center Tel Hashomer, Israel 收起 << |
NCT01341717 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | India ... 展开 >> Jothydev's Diabetes and Research Center Thiruvananthapuram, Kerala, India, 695032 收起 << |
NCT00511108 | Type 2 Diabetes Mellitus (T2DM... 展开 >>) 收起 << | Phase 1 | Completed | - | - |
NCT00722371 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00722371 | - | Completed | - | - | |
NCT00511108 | - | Completed | - | - | |
NCT00729326 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Texas ... 展开 >> Research Site San Antonio, Texas, United States 收起 << |
NCT01357135 | - | Completed | - | - | |
NCT00729326 | - | Completed | - | - | |
NCT02200991 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Investigational Site Number 392-107 Atsugi-shi, Japan Investigational Site Number 392-125 Chiyoda-ku, Japan Investigational Site Number 392-121 Chuoh-ku, Japan Investigational Site Number 392-102 Ichihara-shi, Japan Investigational Site Number 392-103 Kawaguchi-shi, Japan Investigational Site Number 392-114 Kitamoto-shi, Japan Investigational Site Number 392-122 Kobe-shi, Japan Investigational Site Number 392-126 Kumamoto-shi, Japan Investigational Site Number 392-127 Kumamoto-shi, Japan Investigational Site Number 392-101 Kyoto-shi, Japan Investigational Site Number 392-106 Matsudo-shi, Japan Investigational Site Number 392-124 Mitaka-shi, Japan Investigational Site Number 392-108 Mito-shi, Japan Investigational Site Number 392-119 Nerima-ku, Japan Investigational Site Number 392-117 Okayama-shi, Japan Investigational Site Number 392-111 Sagamihara-shi, Japan Investigational Site Number 392-110 Sapporo-shi, Japan Investigational Site Number 392-116 Satsumasendai-shi, Japan Investigational Site Number 392-105 Shizuoka-shi, Japan Investigational Site Number 392-118 Suita-shi, Japan 收起 << |
NCT01936025 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 << |
NCT01357135 | - | Completed | - | - | |
NCT00637273 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02008682 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | China, Beijing ... 展开 >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100071 Novo Nordisk Investigational Site Beijing, Beijing, China, 100700 Novo Nordisk Investigational Site Beijing, Beijing, China, 100853 China, Chongqing Novo Nordisk Investigational Site ChongQing, Chongqing, China, 404000 China, Hebei Novo Nordisk Investigational Site Cangzhou, Hebei, China, 061000 Novo Nordisk Investigational Site Hengshui, Hebei, China, 053000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050051 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210011 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210012 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210029 Novo Nordisk Investigational Site Suzhou, Jiangsu, China, 215004 Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 Novo Nordisk Investigational Site Zhenjiang, Jiangsu, China, 212001 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Jilin Novo Nordisk Investigational Site Changchun, Jilin, China, 130041 China, Liaoning Novo Nordisk Investigational Site Dalian, Liaoning, China, 116033 Novo Nordisk Investigational Site Shenyang, Liaoning, China, 110021 China, Shandong Novo Nordisk Investigational Site Qingdao, Shandong, China, 266003 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200080 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200092 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200120 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200240 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 201199 China Novo Nordisk Investigational Site Beijing, China, 101200 收起 << |
NCT00637273 | - | Completed | - | - | |
NCT01907854 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT02008682 | - | Completed | - | - | |
NCT02824874 | Diabetes Mellitus, Type II | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of 收起 << |
NCT03267576 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Mexico ... 展开 >> Consultorio Privado Guadalajara, Mexico, 44150 Investigación Clínica Especializada Guadalajara, Mexico, 44600 Consultorio Privado en Unidad de Patología Clínica Guadalajara, Mexico, 44650 Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14080 Hospital Universitario 'Dr. Jose Eleuterio Gonzalez' Monterrey, Mexico, 64460 收起 << |
NCT00397631 | - | Completed | - | - | |
NCT00397631 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00768651 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 收起 << |
NCT01717911 | Type 2 Diabetes | Phase 4 | Unknown | December 2018 | Taiwan ... 展开 >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD 886-2-28757515 chenhs@vghtpe.gov.tw Principal Investigator: Harn-Shen Chen, MD, PhD 收起 << |
NCT00768651 | - | Completed | - | - | |
NCT01441232 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT00971659 | Type 2 Diabetes | Phase 1 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 << |
NCT00975052 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT01907854 | - | Completed | - | - | |
NCT00813228 | Diabetes Mellitus Type 1 ... 展开 >> Diabetes Mellitus Type 2 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01422590 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT03078049 | - | Completed | - | United States, Delaware ... 展开 >> Research Site Wilmington, Delaware, United States, 19803 收起 << | |
NCT02254291 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 收起 << |
NCT01841697 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02254291 | - | Completed | - | - | |
NCT01841697 | - | Completed | - | - | |
NCT01879228 | Cystic Fibrosis ... 展开 >> Pancreatic Insufficiency 收起 << | Not Applicable | Recruiting | December 2018 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia and University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19194 Contact: Christina Kubrak, RRT 267-426-5135 Principal Investigator: Michael M Rickels, MD, MS Principal Investigator: Andrea Kelly, M.D., M.S 收起 << |
NCT00721552 | Diabetes Mellitus ... 展开 >> Steroid Diabetes Glucocorticoid-induced Diabetes Beta-cell Function 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> VUmc Diabetes Center Amsterdam, Noord-Holland, Netherlands, 1081 HV 收起 << |
NCT00875394 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 3 | Completed | - | - |
NCT00957060 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Guatemala ... 展开 >> Sanofi-Aventis Administrative Office Guatemala City, Guatemala Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico 收起 << |
NCT00103857 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00842556 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Ppd Development Austin, Texas, United States, 78744 收起 << |
NCT00532935 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00103857 | - | Completed | - | - | |
NCT00875394 | - | Completed | - | - | |
NCT00484419 | Type 2 Diabetes ... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> La Mesa, California, United States Los Angeles, California, United States Los Gatos, California, United States San Antonio, California, United States United States, Florida Chiefland, Florida, United States United States, Indiana Gary, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Dearborn, Michigan, United States W. Bloomfield, Michigan, United States United States, Nevada Las Vegas, Nevada, United States United States, New York Yonkers, New York, United States United States, North Carolina Lexington, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Munroe Falls, Ohio, United States Zaneville, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Jersey Shore, Pennsylvania, United States United States, South Carolina Clemson, South Carolina, United States United States, Tennessee Harriman, Tennessee, United States United States, Texas Dallas, Texas, United States 收起 << |
NCT00484419 | - | Completed | - | - | |
NCT01602003 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> LG Life Sciences Seoul, Korea, Republic of, 110-062 收起 << |
NCT01610154 | Insulin Secretion ... 展开 >> Insulin Resistance 收起 << | Phase 4 | Completed | - | China ... 展开 >> Fuwai Hospital Beijing, China 收起 << |
NCT00094770 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00532935 | - | Completed | - | - | |
NCT01890629 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT01760447 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | September 13, 2019 | - |
NCT02849080 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Active, not recruiting | April 5, 2019 | - |
NCT01610154 | - | Completed | - | - | |
NCT01296412 | - | Completed | - | - | |
NCT00094770 | - | Completed | - | - | |
NCT00766441 | Diabetes Hypo... 展开 >>glycemia 收起 << | Phase 4 | Terminated(inadequate recruitm... 展开 >>ent) 收起 << | - | United Kingdom ... 展开 >> Wellcome Trust Clinical Research Facility Manchester, United Kingdom, M13 9NT 收起 << |
NCT01076088 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01076088 | - | Completed | - | - | |
NCT00993187 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT01296412 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01096277 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | December 2012 | Germany ... 展开 >> Hannover Medical School Not yet recruiting Hannover, Germany, 30625 Contact: Sajoscha A. Sorrentino, MD sorrentino.sajoscha@mh-hannover.de Principal Investigator: Sajoscha A. Sorrentino, MD 收起 << |
NCT00993187 | - | Completed | - | - | |
NCT00545584 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 3 | Completed | - | - |
NCT02556918 | Hyperglycemia | Phase 4 | Recruiting | March 2019 | United States, Georgia ... 展开 >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo Umpierrez, MD 404-778-1665 geumpie@emory.edu Emory Univeristy Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Guillermo Umpierrez, MD 404-778-1665 geumpie@emory.edu Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD 404-778-1665 收起 << |
NCT02226003 | - | Completed | - | - | |
NCT02226003 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00545584 | - | Completed | - | - | |
NCT01409213 | - | Completed | - | - | |
NCT01624116 | Diabetes, Type 2 | Not Applicable | Completed | - | Pakistan ... 展开 >> Endocrinology Unit & Diabetes Management Centre, Services Hospital. Lahore, Pakistan 收起 << |
NCT01409213 | - | Completed | - | - | |
NCT00860288 | Diabetes Mellitus, Type 2 | Phase 2 Phase 3 | Completed | - | - |
NCT02946632 | Diabetes Mellitus, Type II | Phase 3 | Not yet recruiting | December 2019 | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT01278485 | - | Completed | - | - | |
NCT01285076 | - | Completed | - | Taiwan ... 展开 >> Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan, 106 收起 << | |
NCT01285076 | - | Completed | - | - | |
NCT02743260 | Healthy | Phase 4 | Unknown | December 2017 | Germany ... 展开 >> Department of Pharmacology I, University Hospital Cologne Cologne, NRW, Germany, 50931 收起 << |
NCT02882477 | Diabetes Mellitus ... 展开 >> Iron Metabolism Disorders Gastroduodenal Ulcer Optic Atrophy Sensorineural Hearing Loss Platelet Dysfunction 收起 << | Phase 2 Phase 3 | Unknown | December 2018 | Israel ... 展开 >> Hadassah medical center Recruiting Jerusalem, Israel Contact: David Zangen, Professor 0097507874488 zanegnd@hadassah.org.il Contact: Ulla Najwa Abdulhag, MD 0097505172866 najwa.ped@gmail.com 收起 << |
NCT01794143 | Type 2 Diabetes ... 展开 >> Comparative Effectiveness of Glycemia-lowering Medications 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT01588587 | - | Unknown | December 2017 | Japan ... 展开 >> Kurume University Not yet recruiting Kurume, Fukuoka, Japan, 830-0111 Contact: Sho-ichi Yamagishi, MD +81-942-31-7873 shoichi@med.kurume-u.ac.jp Sub-Investigator: Sho-ichi Yamagishi, MD Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD +81-0258-28-3600 kkam-int@echogo.ne.jp Principal Investigator: Kyuzi Kamoi, MD Sub-Investigator: Sho-ichi Yamagishi, MD 收起 << | |
NCT01106690 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00837759 | Diabetes Mellitus Type 1 ... 展开 >> Autoimmune Diabetes 收起 << | Phase 2 | Terminated(Changes to study pe... 展开 >>rsonnel.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01545024 | - | Unknown | January 2013 | Japan ... 展开 >> Nagaoka Red Cross Hospital Recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD +81-0258-28-3600 kkam-int@echigo.ne.jp Principal Investigator: Kyuzi Kamoi, MD 收起 << | |
NCT02653131 | Short Bowel Syndrome | Phase 4 | Unknown | December 2017 | Poland ... 展开 >> Stanley Dudrick's Memorial Hospital Recruiting Skawina, Poland, 32-050 Contact: Stanislaw Klek, Assoc. Prof. +48604293566 klek@poczta.onet.pl Principal Investigator: Stanislaw Klek, Assoc. Prof. 收起 << |
NCT01278485 | - | Completed | - | - | |
NCT03646721 | Diabetes Mellitus, Type 2 | Phase 1 | Recruiting | October 7, 2019 | United States, California ... 展开 >> Clinical Site Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD 619-943-6328 ext 217 Julie.Willard@prosciento.com 收起 << |
NCT01128621 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 收起 << |
NCT00837759 | - | Terminated(Changes to study pe... 展开 >>rsonnel.) 收起 << | - | - | |
NCT01035879 | Diabetes | Phase 2 | Completed | - | United States, California ... 展开 >> Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, New York United Medical Associates Binghamton, New York, United States, 13901 United States, Texas dgd Research, Inc., a Cetero Research Co. San Antonio, Texas, United States, 78229 Georgia Healthy Life Clinical Diagnostic Center Tbilisi, Georgia, 0144 Georgian Diabetes Center Tbilisi, Georgia, 0159 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 India Bharti Research Institute of Diabetes and Endocrinology Karnal, Haryana, India, 132001 Diabetes Thyroid Hormone Research Institute Pvt Ltd Indore, M.p., India, 452001 Gandhi Endocrinology & Diabetes Centre Ramdaspeth, Nagpur, India, 10 Gokula Metropolis Research, MS Ramaiah Memorial Hospital Bangalore, India, 560 054 Medisys Clinisearch India Pvt Ltd Bangalore, India, 560043 Hormone Care Research Centre Ghaziabad, India, 201002 Bangalore Endocrinology & Diabetes Research Centre Malleshwaram, India, 560 003 收起 << |
NCT01081834 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT03101930 | Obesity PreDi... 展开 >>abetes 收起 << | Phase 4 | Recruiting | September 1, 2021 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Dustin Mayfield, RN 615-343-8701 Contact: Nancy J Brown, MD 6153438701 nancy.j.brown@vanderbilt.edu 收起 << |
NCT00881530 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01619332 | Type II Diabetes | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78209 收起 << |
NCT01128621 | - | Completed | - | - | |
NCT01081834 | - | Completed | - | - | |
NCT00780715 | - | Completed | - | - | |
NCT00780715 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United Kingdom ... 展开 >> Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY 收起 << |
NCT03738878 | Hypertension | Phase 4 | Recruiting | December 31, 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37205 Contact: Nancy J Brown, MD 615-343-8701 Contact: Dustin Mayfield, RN 615-343-8701 收起 << |
NCT03717688 | Diabetes Hear... 展开 >>t Failure 收起 << | Phase 4 | Recruiting | January 31, 2019 | Denmark ... 展开 >> University of Copenhagen Recruiting Copenhagen, Denmark, 2100 Contact: Peter Plomgaard, MD, PhD 35451397 Peter.Plomgaard@regionh.dk Principal Investigator: Peter Plomgaard, MD, PhD 收起 << |
NCT01073826 | Diabetes Mellitus, Type 2 ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Zurich Zurich, Switzerland 收起 << |
NCT01106690 | - | Completed | - | - | |
NCT01744236 | Type 2 Diabetes | Phase 4 | Completed | - | Netherlands ... 展开 >> VU University Medical Center Amsterdam, Netherlands, 1081HV 收起 << |
NCT02639637 | - | Completed | - | - | |
NCT00881530 | - | Completed | - | - | |
NCT00998686 | Type 2 Diabetes Mellitus | Phase 3 | Terminated | November 2011 | - |
NCT01376323 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT02647320 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT01475461 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT02639637 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02077946 | - | Completed | - | Sweden ... 展开 >> Novo Nordisk Investigational Site Malmö, Sweden, 202 15 收起 << | |
NCT00760344 | Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00806520 | - | Completed | - | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Nevada Palm Medical Group Las Vegas, Nevada, United States, 89148 United States, North Carolina University of North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Washington Rockwood Clinic Spokane, Washington, United States, 99202 收起 << | |
NCT00958269 | Type 2 Diabetes Mellitus ... 展开 >> Renal Impairment 收起 << | Phase 3 | Terminated(Technical/operation... 展开 >>al issues) 收起 << | November 2011 | - |
NCT00984867 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02940184 | Physiology | Not Applicable | Recruiting | October 2018 | Denmark ... 展开 >> Department of Surgery C, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Simon Veedfald, MD +45 41 10 25 95 Contact: Lars Bo Svendsen, Dr.Med.Sci +45 35 45 21 22 Lars.Bo.Svendsen@regionh.dk Principal Investigator: Simon Veedfald, MD 收起 << |
NCT00984867 | - | Completed | - | - | |
NCT01376323 | - | Completed | - | - | |
NCT01089790 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated | - | - |
NCT01093651 | Diabetes Insu... 展开 >>lin Resistance 收起 << | Phase 2 Phase 3 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02315287 | Type 2 Diabetes | Phase 4 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD 82-31-787-7035 limsoo@snu.ac.kr Contact: Eu Jeong Ku, MD 82-31-787-6232 eujeong.ku@gmail.com Principal Investigator: Soo Lim, MD, PHD 收起 << |
NCT02647320 | - | Completed | - | - | |
NCT00881543 | Diabetes Type 2 | Not Applicable | Completed | - | Brazil ... 展开 >> University of São Paulo General Hospital São Paulo, Brazil 收起 << |
NCT01093651 | - | Completed | - | - | |
NCT02336659 | Severe Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT02697253 | Obesity | Phase 2 | Active, not recruiting | December 2020 | United States, New York ... 展开 >> Columbia University Medical Center - Russ Berrie Building New York, New York, United States, 10032 收起 << |
NCT01475461 | - | Completed | - | - | |
NCT02188186 | Type 2 Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 收起 << |
NCT02802644 | Acute Coronary Syndrome ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 4 | Recruiting | - | Korea, Republic of ... 展开 >> Keimyung University Hospital Not yet recruiting Daegu, Korea, Republic of Principal Investigator: Chang-Wook Nam, MD, PhD Chonnam National University Hospital Not yet recruiting Gwangju, Korea, Republic of Principal Investigator: Young Joon Hong, MD, PhD Jeju National University Hospital Not yet recruiting Jeju, Korea, Republic of Principal Investigator: Ki-Seok Kim, MD, PhD Chung-Ang University Hospital Recruiting Seoul, Korea, Republic of, 06973 Principal Investigator: Sang-Wook Kim, MD, PhD Korea University Guro Hospital Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Seung-Woon Rha, MD, PhD Ajou University Hospital Not yet recruiting Suwon, Korea, Republic of Principal Investigator: So-Yeon Choi, MD, PhD 收起 << |
NCT02653209 | Type 2 Diabetes | Phase 4 | Recruiting | December 2019 | United Kingdom ... 展开 >> Exeter Clinical Research Facility Recruiting Exeter, United Kingdom, EX2 5DW Contact: Catherine Angwin 01392408185 C.Angwin@exeter.ac.uk Contact: Andrew Hattersley +441392 408231 A.T.Hattersley@exeter.ac.uk Principal Investigator: Andrew Hattersley 收起 << |
NCT01660386 | Type 2 Diabetes | Phase 4 | Unknown | March 2013 | China ... 展开 >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China, 200021 Contact: Guang Ning, MD,PHD +8621-64370045 ext 665340 guangning@medmail.com.cn Principal Investigator: Guang Ning, MD,PHD 收起 << |
NCT02689362 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Brazil ... 展开 >> Centro de Estudos em Diabetes e Hipertensão Fortaleza, Ceará, Brazil Hospital Universitário João de Barros Barreto - HUJBB Belém, Pará, Brazil CCBR Brasil Centro de Pesquisas e Analises Clinicas Ltda Rio de Janeiro, Brazil Centro de Pesquisa Clínica em Diabetes - UNIFESP São Paulo, Brazil CEPIC - Centro Paulista de Investigação Clínica São Paulo, Brazil Clinica de Endocrinologia e Metabologia LTDA São Paulo, Brazil CPCLIN - Centro de Pesquisas Clinicas LTDA São Paulo, Brazil HCFMUSP São Paulo, Brazil IMA - Instituto de Pesquisa Clínica e Medicina Avançada Ltda São Paulo, Brazil IPEC - Instituto de Pesquisa Clínica Ltda São Paulo, Brazil 收起 << |
NCT02405260 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mesa, Arizona, United States, 85213 Tuscon, Arizona, United States, 85741 United States, California Canoga Park, California, United States, 91303 Huntington Park, California, United States, 90255 Los Angeles, California, United States, 90056 West Hills, California, United States, 91307 United States, Colorado Centennial, Colorado, United States, 80112 Littleton, Colorado, United States, 80127 United States, Connecticut Waterbury, Connecticut, United States, 06708 United States, Florida West Palm Beach, Florida, United States, 33409 United States, Illinois Gurnee, Illinois, United States, 60031 United States, Indiana Evansville, Indiana, United States, 47725 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Greensboro, North Carolina, United States, 27408 United States, South Carolina Moncks Corner, South Carolina, United States, 29461 United States, Texas San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78229 Schertz, Texas, United States, 78154 United States, Virginia Norfolk, Virginia, United States, 23507 United States, Washington Richland, Washington, United States, 99352 收起 << |
NCT02130687 | Type 2 Diabetes Mellitus ... 展开 >> Hypertension 收起 << | Not Applicable | Recruiting | June 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D. jessica.r.wilson@vanderbilt.edu Contact: Scott Hubers, M.D. scott.hubers@vanderbilt.edu Principal Investigator: Nancy J Brown, M.D. Sub-Investigator: Jessica Devin, M.D. Sub-Investigator: Jessica R Wilson, M.D. Sub-Investigator: Claudia E Ramirez, M.D. Sub-Investigator: Scott Hubers, M.D. 收起 << |
NCT02111096 | Diabetes Mellitus, Type 2 | Phase 2 | Terminated(The overall benefit... 展开 >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) 收起 << | - | - |
NCT00964184 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | India ... 展开 >> Fortis Flt Lt Rajan Dhall Hospital New Delhi, Delhi, India, 110070 收起 << |
NCT00716092 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Germany ... 展开 >> 1218.37.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1218.37.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1218.37.49001 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 << |
NCT01235819 | Type 1 Diabetes | Phase 4 | Completed | - | India ... 展开 >> Command Hospital Lucknow, UP, India, 226002 收起 << |
NCT01471808 | Diabetes Mellitus, Type 2 | Phase 4 | Enrolling by invitation | December 2021 | - |
NCT02089438 | Type 2 Diabetes | Phase 4 | Completed | - | Sweden ... 展开 >> Clinical Research Department Lund, Sweden, 22185 收起 << |
NCT00795275 | Obesity | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver Aurora, Colorado, United States, 80045 收起 << |
NCT02111096 | - | Terminated(The overall benefit... 展开 >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) 收起 << | - | - | |
NCT03593135 | Randomized Controlled Trial ... 展开 >> Diabetes Mellitus 收起 << | Not Applicable | Completed | - | Pakistan ... 展开 >> Shaikh Zayed Medical Complex Lahore, Punjab, Pakistan, 54000 收起 << |
NCT03233178 | - | Completed | - | Canada, Ontario ... 展开 >> LMC Brampton Brampton, Ontario, Canada, L6S 0C9 收起 << | |
NCT00838903 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00838903 | - | Completed | - | - | |
NCT00716092 | - | Completed | - | - | |
NCT01341795 | - | Unknown | - | Korea, Republic of ... 展开 >> Ajou University School of Medicine Recruiting Suwon, Gyeonggi, Korea, Republic of, 433-721 Contact: Doo-Yeoun Cho, MD +82-31-219-4271 dooycho@ajou.ac.kr Sub-Investigator: Young-Sang Kim, MD 收起 << | |
NCT01140438 | Diabetes | Not Applicable | Active, not recruiting | December 2018 | Norway ... 展开 >> Valdemar Grill Trondheim, Norway, 7006 收起 << |
NCT02127047 | Diabetes Mellitus Type 1 | Phase 2 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT02202161 | - | Completed | - | - | |
NCT02567994 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT01193296 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | France ... 展开 >> Investigative Site Bondy, France Investigative Site Corbeil, France Investigative Site Marseille, France Investigative Site Nancy, France Investigative Site Paris, France Investigative Site Toulouse, France Investigative Site Venissieux, France 收起 << |
NCT02202161 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT00642278 | Diabetes Mellitus, Type II ... 展开 >> Diabetes Mellitus, Non Insulin Dependent 收起 << | Phase 2 | Completed | - | - |
NCT00747383 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | United Kingdom ... 展开 >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW 收起 << |
NCT01701973 | Obesity | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT00642278 | - | Completed | - | - | |
NCT01701973 | - | Completed | - | - | |
NCT01847144 | Type 2 Diabetes | Phase 4 | Completed | - | United Kingdom ... 展开 >> NIHR Exeter Clinical Research Facility, Royal Devon & Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX2 5DW 收起 << |
NCT01338870 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01332370 | - | Completed | - | - | |
NCT02363335 | Healthy Volunteers | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 收起 << |
NCT01338870 | - | Completed | - | - | |
NCT01289990 | - | Completed | - | - | |
NCT03108521 | Diabetes Mellitus | Phase 4 | Recruiting | March 2019 | China, Sichuan ... 展开 >> Sichuan provincial people's hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Enwu Long, Master +86 2887393316 dragon984169@126.com 收起 << |
NCT02386943 | Type 2 Diabetes | Phase 4 | Unknown | March 2015 | China ... 展开 >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China Contact: Ning Guang, MD,PHD 收起 << |
NCT02406443 | Type 2 Diabetes | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> University Health Network - Division of Nephrology Toronto, Ontario, Canada, M5G 2N2 收起 << |
NCT03602638 | Atherosclerosis Type 2 Diabete... 展开 >>s Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 收起 << | Phase 4 | Not yet recruiting | December 1, 2020 | - |
NCT01289990 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02406443 | - | Completed | - | - | |
NCT01106677 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01336738 | Diabetes, Type 2 | Phase 2 | Completed | - | - |
NCT00749190 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01106677 | - | Completed | - | - | |
NCT01336738 | - | Completed | - | - | |
NCT02628392 | Type2 Diabetes Mellitus | Not Applicable | Completed | - | Japan ... 展开 >> Heishinkai Medical Group Incorporated OCROM Clinic Suita-shi, Osaka, Japan 收起 << |
NCT01272583 | Type 1 Diabetes ... 展开 >> Hypoglycemia 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Academic Medical Center Amsterdam, Noord Holland, Netherlands, 1100DD 收起 << |
NCT01272583 | - | Completed | - | - | |
NCT00631488 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00106704 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00106704 | - | Completed | - | - | |
NCT00749190 | - | Completed | - | - | |
NCT01933672 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Florida ... 展开 >> Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 United States, Texas Clinical Trials of Texas, Inc San Antonio, Texas, United States, 78229 Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 United States, Wisconsin Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 收起 << |
NCT02452632 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Site KR00002 Busan, Korea, Republic of Site KR00003 Busan, Korea, Republic of Site KR00007 Daegu, Korea, Republic of Site KR00011 Daegu, Korea, Republic of Site KR00019 Dong Gu Gwangju, Korea, Republic of Site KR00008 Gangwon-do, Korea, Republic of Site KR00018 Gyeonggi-do, Korea, Republic of Site KR00022 Gyeonggi-do, Korea, Republic of Site KR00014 Incheon, Korea, Republic of Site KR00020 Jeollabuk-do, Korea, Republic of Site KR00021 Kyungsangnam-do, Korea, Republic of Site KR00001 Seoul, Korea, Republic of Site KR00004 Seoul, Korea, Republic of Site KR00005 Seoul, Korea, Republic of Site KR00006 Seoul, Korea, Republic of Site KR00009 Seoul, Korea, Republic of Site KR00010 Seoul, Korea, Republic of Site KR00012 Seoul, Korea, Republic of Site KR00013 Seoul, Korea, Republic of Site KR00016 Seoul, Korea, Republic of Site KR00017 Seoul, Korea, Republic of Site KR00015 Suwon, Korea, Republic of 收起 << |
NCT00418366 | Renal Insufficiency ... 展开 >> Hemodialysis 收起 << | Phase 1 | Completed | - | - |
NCT00947011 | - | Terminated(PI left JHU) | - | - | |
NCT00947011 | Glucose Homeostasis | Phase 2 | Terminated(PI left JHU) | - | United States, Maryland ... 展开 >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 收起 << |
NCT00673894 | Type 2 Diabetes | Phase 1 | Unknown | June 2010 | Australia, New South Wales ... 展开 >> Clinical Research Facility Recruiting Sydney, New South Wales, Australia, 2010 Contact: Dr J Greenfield, FRACP 612-9295-8100 ext 8217 j.greenfield@garvan.org.au Principal Investigator: Jerry Greenfield, FRACP 收起 << |
NCT01937598 | - | Completed | - | - | |
NCT01937598 | Type 2 Diabetes | Phase 3 | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 收起 << |
NCT02025907 | - | Completed | - | - | |
NCT01933672 | - | Completed | - | - | |
NCT01059825 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01855087 | - | Completed | - | Japan ... 展开 >> Takai Naika Clinic Kamakura, Kanagawa, Japan, 247-0056 收起 << | |
NCT01895569 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | June 2016 | Italy ... 展开 >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD giuseppe.derosa@unipv.it Contact: Pamela Maffioli, MD pamelamaffioli@hotmail.it Principal Investigator: Giuseppe Derosa, MD, PhD Sub-Investigator: Pamela Maffioli, MD 收起 << |
NCT00976261 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45212 France GSK Investigational Site Gières, France, 38610 GSK Investigational Site Rueil-Malmaison, France, 92502 Germany GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22769 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG 收起 << |
NCT01059825 | - | Completed | - | - | |
NCT00411411 | Type 2 Diabetes | Phase 3 | Completed | - | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT00631488 | - | Completed | - | - | |
NCT00411411 | - | Completed | - | - | |
NCT02749032 | Type 2 Diabetes | Phase 1 | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 收起 << |
NCT01824264 | Type 2 Diabetes Mellitus | Phase 2 | Withdrawn | November 2016 | - |
NCT01413542 | Hypertension ... 展开 >>Diabetes Type 2 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University- General Clinic Research Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02025907 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT01413542 | - | Completed | - | - | |
NCT03492580 | - | Completed | - | United States, New Jersey ... 展开 >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 收起 << | |
NCT02333591 | Coronary Microvascular Dysfunc... 展开 >>tion 收起 << | Phase 4 | Recruiting | November 2018 | Denmark ... 展开 >> Department of Research in Endocrinology, Bispebjerg University Hospital Recruiting Copenhagen, Denmark, 2400 Contact: Malin Nilsson, MD +4540259871 mnil0028@regionh.dk Contact: Mette Zander, associated prof. +4551543686 m.zander@dadlnet.dk 收起 << |
NCT02312427 | Heart Failure ... 展开 >> Diabetes Mellitus 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Mitsui Memorial Hospital Taito-ku, Tokyo, Japan 收起 << |
NCT01077323 | - | Completed | - | United States, Massachusetts ... 展开 >> Research Site Waltham, Massachusetts, United States 收起 << | |
NCT01077323 | - | Completed | - | - | |
NCT03746769 | Diabetes Mellitus, Type 1 | Phase 1 Phase 2 | Not yet recruiting | December 2023 | United States, California ... 展开 >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Principal Investigator: Fouad Kandeel, MD, PhD 收起 << |
NCT01974544 | Type 2 Diabetes | Not Applicable | Unknown | December 2016 | Chile ... 展开 >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse 56223543527 macastia@uc.cl Contact: Vega Andrea, Nurse 56223543879 abvega@uc.cl Principal Investigator: Boza Camilo, MD surgeon Sub-Investigator: Valderas Juan Patricio, MD Sub-Investigator: Arrese Marco, MD Internist Sub-Investigator: Muñoz Rodrigo, MD 收起 << |
NCT02528019 | Effects of the DPP-4 Inhibitor... 展开 >>s or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications 收起 << | Phase 4 | Unknown | August 2018 | Japan ... 展开 >> Kurume University Hospital Recruiting Kurume city, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD +81-942-31-7580 ntahara@med.kurume-u.ac.jp Contact: Sho-ichi Yamagishi, MD, PhD +81-942-31-7562 Principal Investigator: Nobuhiro Tahara, MD, PhD 收起 << |
NCT02456428 | - | Completed | - | Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 << | |
NCT02476760 | - | Completed | - | Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 << | |
NCT02368704 | - | Unknown | November 2016 | France ... 展开 >> Saint-Louis Hospital Paris, France, 75010 收起 << | |
NCT02244164 | Type 2 Diabetes ... 展开 >> Incretinomimetics Pancreas 收起 << | Not Applicable | Recruiting | - | Belgium ... 展开 >> Gastroenterology Department Erasme Hospital Recruiting Brussels, Belgium, 1070 Contact: Vincent Huberty, MD +3225553715 vincent.huberty@erasme.ulb.ac.be 收起 << |
NCT00950534 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(due to poor recruit... 展开 >>ment) 收起 << | - | Australia ... 展开 >> Sanofi-Aventis Administrative Office Macquarie Park, Australia 收起 << |
NCT02610088 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 收起 << |
NCT03014479 | Type 2 Diabetes | Phase 4 | Completed | - | Japan ... 展开 >> Nagoya, Aichi, Japan Kanra, Gunma, Japan Kobe, Hyogo, Japan Koga, Ibaraki, Japan Kawasaki, Kanagawa, Japan Sagamihara, Kanagawa, Japan Yamato, Kanagawa, Japan Sendai, Miyagi, Japan Kashihara, Nara, Japan Kashiwara, Osaka, Japan Suita, Osaka, Japan Okegawa, Saitama, Japan Oyama, Tochigi, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Edogawa-ku, Tokyo, Japan Musashino, Tokyo, Japan Oota-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinagawa-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shinjyuku-ku, Tokyo, Japan Osaka, Japan 收起 << |
NCT01162772 | - | Unknown | - | Austria ... 展开 >> Medical University of Viemma Recruiting Vienna, Austria, 1090 Contact: Jeanette Strametz-Juranek, MD 0043140400 ext 4618 jeanette.strametz-juranek@meduniwien.ac.at Contact: Alexandra Kautzky-Willer, MD 0140400 ext 4316 alexandra.kautzky-willer@meduniwien.ac.at Principal Investigator: Jeanette Strametz-Juranek, MD Principal Investigator: Alexandra Kautzky-Willer, MD Sub-Investigator: Alia Sabri, MD Sub-Investigator: Lana Kosi, MD 收起 << | |
NCT02130778 | Sodium Excretion by Urination | Early Phase 1 | Completed | - | Croatia ... 展开 >> University Hospital Centre Zagreb, Croatia, 10 000 University hospital Centre Zagreb Zagreb, Croatia, 10000 收起 << |
NCT00426413 | - | Completed | - | United States, Georgia ... 展开 >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 收起 << | |
NCT02280174 | Type 2 Diabetes | Phase 4 | Unknown | October 2016 | Argentina ... 展开 >> National University of Formosa Recruiting Formosa, Argentina, 3600 Contact: Juan Pa Nogueira, MD/PhD 00543704425447 nogueirajuanpatricio@gmail.com 收起 << |
NCT03146208 | - | Not yet recruiting | January 20, 2019 | - | |
NCT00684528 | Diabetes Type 2 | Phase 3 | Unknown | December 2012 | Israel ... 展开 >> Clalit Health services center Recruiting Tel Aviv, Israel, 62098 Contact: Zinger 972-5062-63652 Principal Investigator: Zinger Joel, MD 收起 << |
NCT02725502 | Type 1 Diabetes Mellitus | Not Applicable | Unknown | May 2016 | India ... 展开 >> Department of Endocrinology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Snajay Kr Bhadada, MD, DM bhadadask@rediffmail.com Contact: Soham Mukherjee, MD 9914743222 drsoham.mukherjee@gmail.com Principal Investigator: sanjay Kr Bhadada, MD, DM 收起 << |
NCT00901979 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT02475499 | - | Completed | - | Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 << | |
NCT02138097 | - | Completed | - | United States, Massachusetts ... 展开 >> 1218.161.1 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States 收起 << | |
NCT01944618 | - | Terminated() | - | Australia, Victoria ... 展开 >> Local Institution Clayton, Victoria, Australia, VIC 3168 收起 << | |
NCT02138097 | - | Completed | - | - | |
NCT01269996 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Hong Kong ... 展开 >> Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong 收起 << |
NCT02871882 | Type 2 Diabetes Mellitus ... 展开 >> Obese Overweight 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << |
NCT02072096 | - | Terminated(The trial was termi... 展开 >>nated per protocol because of lack of feasibility.) 收起 << | - | - | |
NCT00855166 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Bulgaria ... 展开 >> Research Site Blagoevgrad, Bulgaria Research Site Sofia, Bulgaria Czech Republic Research Site Beroun, Czech Republic Research Site Brno, Czech Republic Research Site Praha, Czech Republic Research Site Semily, Czech Republic Research Site Slany, Czech Republic Hungary Research Site Balatonfured, Hungary Research Site Budapest, Hungary Research Site Csongrad, Hungary Research Site Kecskemet, Hungary Research Site TAT, Hungary Poland Research Site Elblag, Poland Research Site Krakow, Poland Research Site Torun, Poland Sweden Research Site Goteborg, Sweden Research Site Jarfalla, Sweden Research Site Lund, Sweden Research Site Malmo, Sweden Research Site Stockholm, Sweden Research Site Uppsala, Sweden 收起 << |
NCT00855166 | - | Completed | - | - | |
NCT02365233 | Type II Diabetes ... 展开 >> Nonalcoholic Fatty Liver 收起 << | Phase 4 | Terminated(IRB withheld the da... 展开 >>ta due to inadequate supporting documentation) 收起 << | - | United States, Texas ... 展开 >> University of Texas Medical Branch -Galveston Galveston, Texas, United States, 77555 收起 << |
NCT02365233 | - | Terminated(IRB withheld the da... 展开 >>ta due to inadequate supporting documentation) 收起 << | - | - | |
NCT02072096 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(The trial was termi... 展开 >>nated per protocol because of lack of feasibility.) 收起 << | - | - |
NCT01969357 | Type 2 Diabetes | Phase 2 | Completed | - | China ... 展开 >> Chinese PLA General Hospital Beijing, China 收起 << |
NCT02060383 | Cushing's Disease ... 展开 >> Acromegaly 收起 << | Phase 4 | Completed | - | - |
NCT01349387 | Type 2 Diabetes | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91106 收起 << |
NCT01342939 | - | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens vej 65, opgang 40, 2. Hellerup, Denmark, 2900 收起 << | |
NCT01767389 | - | Completed | - | - | |
NCT01198730 | Diabetes Mellitus ... 展开 >> Coronary Artery Disease 收起 << | Not Applicable | Recruiting | December 2019 | Taiwan ... 展开 >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Wayne H-H Sheu, MD, PHD whhsheu@vghtc.gov.tw 收起 << |
NCT02493959 | Healthy | Early Phase 1 | Completed | - | Denmark ... 展开 >> Department of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT02879409 | Diabetes Mellitus Type 2 | Not Applicable | Recruiting | August 2019 | Qatar ... 展开 >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: Ibrahim Janahi, MD 4439-2434 ext 00974 Imohd@hamad.qa Principal Investigator: Ibrahim Janahi, MD Sub-Investigator: Mashhood Siddique, MD Sub-Investigator: Hamda Ali, MD 收起 << |
NCT01242228 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan 收起 << |
NCT01999218 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02041234 | Type II Diabetes in Subjects B... 展开 >>MI 27 to 32 收起 << | Phase 4 | Recruiting | March 2020 | Singapore ... 展开 >> Khoo Teck Puat Hospital Recruiting Singapore, Singapore, 768828 Contact: Bernice Tan +65 6602 3169 tan.bernice.lt@alexandrahealth.com.sg Principal Investigator: Anton Cheng, MBBS Sub-Investigator: Chee Fang Sum, MBBS Sub-Investigator: Su Chi Lim, MBBS Sub-Investigator: Tavintharan Subramaniam, MBBS Sub-Investigator: Nitish Mishra, MBBS Sub-Investigator: Ester Yeoh, MBBS Sub-Investigator: Chun Hai Tan, MBBS Sub-Investigator: Benjamin Chih Chiang Lam, MBBS Sub-Investigator: Thazin Ma, MBBS Sub-Investigator: Michael Wong, MBBS 收起 << |
NCT01999218 | - | Completed | - | - | |
NCT03115099 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Singapore, Singapore, 117597 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore 收起 << |
NCT02527993 | Hypoglycemia ... 展开 >>Obesity Surgery 收起 << | Phase 4 | Completed | - | - |
NCT00676338 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00783549 | Dyslipidaemias | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 收起 << |
NCT00871507 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> Fort Myers, Florida, United States United States, Texas San Antonio, Texas, United States 收起 << |
NCT00676338 | - | Completed | - | - | |
NCT03180281 | Type 2 Diabetes Mellitus | Not Applicable | Not yet recruiting | January 1, 2020 | China, Shaanxi ... 展开 >> First Affiliated Hospital of Xi'an Jiao Tong University Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Jing Sui, Doctor 0086-18991989230 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!